Companies that own Zogenix Inc.
Scopia Capital Management LP
5,306,514
12.69%
1,798,786
4.4%
08/31/2018
Perceptive Advisors LLC
4,070,357
9.73%
100,000
4.48%
08/10/2018
BlackRock Fund Advisors
2,599,781
6.22%
158,336
0.01%
06/30/2018
Cadian Capital Management LP
2,051,934
4.91%
-102,340
4.46%
06/30/2018
Farallon Capital Management LLC
1,695,500
4.05%
119,500
0.54%
06/30/2018
The Vanguard Group, Inc.
1,686,146
4.03%
163,691
0%
06/30/2018
venBio Select Advisor LLC
1,503,313
3.59%
314,100
2.48%
06/30/2018
Fidelity Management & Research Co.
1,269,085
3.03%
-252,855
0.01%
06/30/2018
Federated Global Investment Management Corp.
1,149,000
2.75%
-312,200
0.4%
06/30/2018
RA Capital Management LLC
1,145,268
2.74%
0
3.05%
06/30/2018
| Address |
5959 Horton Street
Emeryville California 94608
United States
|
|
Employees
|
- |
| Website |
http://www.zogenix.com |
| Updated |
07/08/2019 |
| Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. |
